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Abstract
A series of tetranuclear [LM3(HFArPz)3OM′][OTf]2 (M, M′ = Fe or Mn) clusters that displays 3-
(2-fluorophenyl)pyrazolate (HFArPz) as bridging ligand is reported. With these complexes 
manganese is demonstrated to facilitate C(sp2) –F bond oxygenation via a putative terminal metal-
oxo species. Moreover, the presence of both ortho C(sp2) –H and C(sp2) –F bonds in proximity 
provides an opportunity to investigate the selectivity of intramolecular C(sp2) –X bond 
oxygenation (X = H or F) in these isostructural compounds. With iron as the apical metal center 
(M′ = Fe) C(sp2) –F bond oxygenation occurs almost exclusively, whereas with manganese (M′ = 
Mn) the opposite reactivity is preferred.
Graphical Abstract
The selectivity of intramolecular C(sp2)–H vs. C(sp2)–F bond oxygenation is examined with a new 
series of [LM3(PhPz)3OM′][OTf]2 (M = M′ = Fe or Mn) clusters. The distribution of metal 
centers within these clusters provide insight into how a single metal center (Fe vs. Mn) can control 
the selectivity in observed oxygenation chemistry. While for iron (M′ = Fe) essentially exclusive 
C(sp2)–F bond oxygenation was observed, with manganese (M′ =Mn), C(sp2)–H oxygenation is 
preferred.
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Terminal high-valent metal oxo species play important roles in many biological relevant 
transformations,[1] including the oxidative metabolism of xenobiotics.[2] An important step 
in the metabolism of these compounds, which includes polyaromatic hydrocarbons (PAHs) 
and pharmaceuticals, is aromatic C(sp2)–H bond hydroxylation.[3] Replacing these aromatic 
C(sp2)–H bonds with fluorine increases metabolic stability,[4] and is an approach regularly 
employed by the pharmaceutical industry to improve the bioavailability of drugs.[5] The 
prevalence of fluorine containing drugs raises important questions regarding the mechanism 
and regioselectivity of fluoroarene hydroxylation by terminal high-valent metal oxo 
moieties.
In vivo/vitro studies with cytochrome P450’s have shown that C(sp2)–H bond hydroxylation 
is the preferred reactivity pathway in various substituted fluorobenzenes.[6] Aromatic 
C(sp2)–F bond hydroxylation, in contrast, is only observed in hexafluorobenzene[7] or in 
para-substituted fluoro anilines[8] and phenols.[9] Other substitution patterns (i.e. meta or 
ortho) result in significant C(sp2)–H hydroxylation.[8a] These studies thus demonstrate a 
clear preferences for C(sp2)–H hydroxylation of fluorinated benzenes by cytochrome P450.
Fewer studies have been reported on the selectivity of fluoroarenes oxygenation with 
synthetic reagents. While C(sp2)–H bond hydroxylation of aromatic substrates by high-
valent metal-oxo species is known,[10] aromatic C(sp2)–F bond hydroxylation is exceedingly 
rare.[11] Only in a few instances the direct involvement of terminal high-valent metal-oxo 
species has been demonstrated.[11d, 11e] Cases that display chemoselective C(sp2)–F 
hydroxylation of fluorobenzenes by metal-oxo species are even rarer.[12] Exclusive C(sp2)–F 
bond hydroxylation ortho to a phenoxide moiety was observed with a dioxo-bridged copper 
complex.[12b] Selective hydroxylation of 4-fluorophenol was reported with a P450 
mimic.[12c] However, no C–F bond activation was observed upon removing the hydroxyl 
substituent (e.g. in 4-fluorotoluene),[12c] suggesting that C(sp2)–H bond hydroxylation 
remains the preferred reactivity pathway with a synthetic terminal high-valent metal oxo 
species. A more extensive study was reported with a N-bridged diiron phthalocyanine 
complex that selectively defluorinates arenes in the presence of other C–H bonds.[12a] 
Systematic studies of the structural features of metal complexes that affect the selectivity of 
C–H vs. C–F bond oxygenation are therefore very rare. Herein, we report a new series of 
iso-structural metal complexes [LM3(HFArPz)3OM′][OTf]2 (Scheme 1: 1, M = M′ = Fe; 2, 
M = Fe, M′ = Mn; 3, M = M′ = Mn) that exhibit opposite selectivity in the intramolecular 
oxygenation of 3-(2-fluorophenyl)pyrazolate (HFArPz) as a function of the identity of the 
metal M.
Recently we reported the intramolecular C–H and C–F bond oxygenation by multimetallic 
complexes of the type [LM3(X2ArPz)3OM][OTf]2 (M = Fe or Mn; X = H or F).[11b, 11c] The 
observed reactivity most likely resulted from putative FeIV- and MnIV-oxo moieties, 
generated from iodosobenzene adducts.[13] In those cases, only one type of bond is sterically 
accessible for activation, therefore exclusive C–H or C–F oxygenation is observed. Given 
the scarcity of information about the metal complex motifs that govern the selectivity of 
C(sp2)–H vs. C(sp2)–F bond oxygenation we used a multinuclear platform to investigate the 
selectivity for series of structurally related complexes. Using our previously reported 
synthetic methodology,[11c] we synthesized [LFe3(HFArPz)3OFe][OTf]2 (1). The crystal 
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structure of 1 (Figure S25) shows the apical iron (Fe4) center coordinated by a μ4-oxo 
moiety and three 3-(2-fluorophenyl)pyrazalote donors. The aryl groups display both ortho 
C(sp2)–H and C(sp2)–F bonds. Based on charge balance, and on the Fe1–O1 (1.915(3) Å), 
Fe2–O1 (1.938(3) Å), and Fe3–O1 (2.144(3) Å) bond distances, the iron oxidation states in 
1 are assigned as [LFeIII2FeII(HFArPz)3OFeII][OTf]2, and are in agreement with those 
observed in previously reported complexes.[11c, 14]
With complex 1 in hand, the selectivity in C(sp2)–H vs. C(sp2)–F bond oxygenation was 
investigated. Treating 1 with 2-(tert-butylsulfonyl)-iodosobenzene (sPhIO; 2.0 equiv.) 
resulted in rapid intramolecular oxygenation as judged by electrospray ionization mass 
spectrometry (Figure 1C). Analysis of an aliquot of the reaction mixture shows that three 
major species are present. No free ligand (m/z = 859.0) or other known multinuclear 
complexes was observed by mass spectrometry. The major peak at m/z = 787.59 is 
consistent with [LFe3(HFArPz)2(OArPz)OFe][OTf]2 (4), suggesting C(sp2)–F bond 
oxygenation. The observed isotope pattern is identical to that simulated for 4 (Figure 1D). 
The smaller peak at m/z = 796.59 is indicative of C(sp2)–H bond oxygenation to generate 
complex [LFe3(HFArPz)2(OFArPz)OFe][OTf]2 (5).[15] The peaks for 5 partially overlap 
with the peak at m/z = 799.10, associated with [LFe3(HFArPz)3OFe(F)][OTf]2, which 
results from fluoride capture by starting material 1, coupled with one electron oxidation.[16] 
The preference for C(sp2)–F bond oxygenation is further supported by 1H NMR 
spectroscopy by comparison of the reaction mixture to authentic samples of 4 and 5. Visual 
inspection revealed that 4 is indeed the major species (Figure S8). In order to quantify the 
ratio between C(sp2)–H and C(sp2)–F bond oxygenation, a calibration curve was constructed 
by integrating the resonances at 31.8 ppm and 33.0 ppm, upon mixing 4 and 5 in known 
concentrations (Figure 1F and Figure S9; blue dots and dashed black trace). Integration of 
the corresponding peaks in the 1H NMR spectrum of crude reaction mixture revealed a 
C(sp2)–F to C(sp2)–H ratio of approximately 8 to 1 (Figure 1F, green dots). A similar ratio 
(9 to 1) was determined based on mass spectrometry data (Figures S18–S20). Integration of 
the 1H-NMR peaks in the presence of an internal standard (Figure S28 and S29), reveals that 
conversion to 4 and 5 occurs between 40–50%. An alternative determination of the yield and 
conversion that relied on acid mediated hydrolysis of the organic fragments was not 
successful. Nonetheless, the NMR and ESI-MS data unequivocally demonstrate that C(sp2)–
F bond oxygenation is the preferred reactivity pathway by almost an order of magnitude 
(Table 1). The preference for C(sp2)–F bond oxygenation is notable, given that the preferred 
reactivity pathway for most terminal high-valent metal oxo complexes, including P450s, is 
C(sp2)–H bond hydroxylation (vide supra).[6] Only three other studies have reported 
selective C(sp2)–F oxygenation in the presence of other C(sp2)–H bonds.[12]
To gain further insight into the selectivity of C(sp2)–F bond oxygenation, modifications 
pertinent to the nature of the apical and core metal centers were performed taking advantage 
of our stepwise synthetic protocol (Scheme 1).[11b, 13] Metal-based effects on C(sp2)–F vs 
C(sp2)–H bond oxygenation for isostructural compounds have not been reported to our 
knowledge. Consequently, isostructural complexes [LM3(HFArPz)3OMn][OTf]2 (2; M = Fe, 
3; M = Mn) were synthesized (Figures S4–S5).
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Addition of sPhIO (2.0 equiv.) to a solution of complex 2 resulted in the oxygenation of both 
C(sp2)–F and C(sp2)–H bonds as judged by ESI-MS (Figure S21–S23) and 1H NMR 
spectroscopy (Figures S12 and S13). Based on known ratios of authentic samples of 
[LFe3(HFArPz)2(OArPz)OMn][OTf]2 (6; m/z = 787.59) and 
[LFe3(HFArPz)2(OFArPz)OMn][OTf]2 (7; m/z = 796.09), the experimental ratio was 
determined at ca.1 to 1.3, favoring C(sp2)–H bond oxygenated product 6 (Figure S23A). 
Using the same procedure, the calibration curve constructed by 1H NMR spectroscopy 
revealed a nearly identical ratio of ca. 1 to 2 (Figure S23B). Similar results were obtained 
upon treating 3 with sPhIO (2.0 equiv.). Based on the ESI-MS data, the experimental ratio of 
[LMn3(HFArPz)2(OArPz)OMn][OTf]2 (8; m/z = 787.59) to 
[LMn3(HFArPz)2(OFArPz)OMn][OTf]2 (9; m/z = 796.09) reveals that C(sp2)–H bond 
oxygenation is clearly favored (Figure S24). However, due the paramagnetic broadening by 
manganese, and difficulties in obtaining sufficiently pure authentic samples of complexes 8 
and 9, a definite C(sp2)–F to C(sp2)–H ratio could not be determined. Nevertheless, the 
oxygenation studies with 2 and 3 indicate that manganese is competent for C(sp2)–F bond 
oxygenation. Notably, while Mn-oxo species have been employed for C–H bond 
halogenation reactions,[17] defluorination reaction involving Mn-oxo species have not been 
reported to the best of our knowledge. The observed reactivity with complexes 2 and 3 thus 
demonstrate the first examples of C(sp2)–F bond oxygenation by a putative Mn-oxo species, 
albeit at a lower selectivity compared to iron (Table 1). While for complex 1 almost 
exclusive C(sp2)–F bond oxygenation is observed,[16] the main reactivity pathway for 
complexes that contain manganese as apical metal center (2 and 3) is C(sp2)–H bond 
oxygenation.[15]
The metal-based selectivity in intramolecular oxygenation with complexes 1–3 is intriguing, 
where the preference for C(sp2)–F over C(sp2)–H bond oxygenation with complex 1 is 
unusual. While many computational studies have investigated the effect of fluorine 
substituents on benzene C(sp2)–H hydroxylation,[18] C(sp2)–F bond hydroxylation in the 
presence of C–H bonds has been evaluated less, likely due to lack of experimental 
demonstrations until recently.[12] In the cases where C(sp2)–F bond oxygenation is observed, 
a mechanism similar to that for benzene hydroxylation has been proposed.[11d, 12a, 19] For 
hexafluorobenzene, a rate limiting electrophilic attack of an FeIV-oxo on the π-system of the 
fluoroarene was proposed, which is followed by fluorine NIH shift. [19] Although rare, such 
fluorine NIH shifts have been observed. [12a, 20] However, independent syntheses of 5 and 7, 
do not suggest such an NIH shift in the present system.[21] Related mechanisms for C(sp2)–
F activation have been proposed as well.[11d] In these mechanistic proposals, after the initial 
electrophilic attack by a metal-oxo, a fluoride anion is eliminated upon electron transfer to 
the arene ring.[11d] Such a pathway might be operating here as well, where the basal metal 
centers could participate in these redox processes by providing the required reducing 
equivalents. The selectivity of C(sp2)–F vs C(sp2)–H bond oxygenation, nonetheless, remain 
unclear. We speculate that the observed differences might be related to the extent of 
stabilization of the developing cationic/radical character on the arene ring en-route to the 
Meisenheimer σ-complex.[1f, 19] Fluorine might play a pivotal role in this stabilization, as it 
is known to stabilize organic radicals.[22]
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Due to the multinuclear nature of the studied complexes and the accessibility of multiple 
oxidation states, a mechanism involving nucleophilic aromatic substitution of fluoride from 
a M(III)-oxide moiety – generated by electron transfer from the trimetallic core to an 
intermediate M(IV)-oxo species – cannot be ruled out. Such nucleophilic intermediates may 
be more accessible with the more reducing and electron rich clusters. In agreement with this 
hypothesis, the higher C(sp2)–F bond oxygenation selectivity of 1 correlates with the most 
negative MIII2MII2/MIII3MII redox couple of compounds 1–3, although the difference with 2 
is small. Such correlation between the reduction potentials of 1–3 and the reactivity of the 
proposed metal-oxo species must be taken cautiously, however, as the structures and 
oxidation states of the precursors and reactivity intermediates are different.
In summary, we employed a series of Mn and Fe clusters to study the selectivity of 
oxygenation of aromatic C(sp2)–F and C(sp2)–H bonds. We demonstrate that Mn is 
competent for defluorination of a pendant fluoroarene via a putative Mn-oxo species. The 
selectivity of bond activation is distinct for the proposed Fe- and Mn-oxo moieties. While 
for iron, C(sp2)–F bond oxygenation is observed almost exclusively, for manganese, C(sp2)–
H oxygenation is slightly preferred. These results may inform the development of selective 
transformation for bond breaking/forming reaction involving fluorine.
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Figure 1. 
(A) Crystal structure of [LFe3(HFArPz)3OMn][OTf]2 (2). Thermal ellipsoids are shown at 
the 50% probability level. Hydrogen atoms, outer sphere counter ions, and co-crystallized 
solvent molecules are not shown for clarity. See Table S1 for a summary of selected bond-
distances and angles. (B) Formation of complexes 4 and 5 by treating complex 1 with sPhIO 
(2 equiv.) for 30 minutes in CH2Cl2. (C) Electrospray ionization mass spectrum (ESI-MS) of 
an aliquot of the crude reaction mixture after treating 1 with sPhIO (2 equiv.) for 30 minutes 
in CH2Cl2. (D–E) Simulated mass spectrum and isotope distribution pattern for 4 
[C84H57F2Fe4N12O5]2+ and 5 [C84H56F3Fe4N12O5]2+. (F) Experimentally determined 
C(sp2)–F to C(sp2)–H ratio (green dots), by integrating the 1H NMR resonances at 31.8 ppm 
and 33.0 ppm belonging to complexes 4 and 5 respectively. The blue dots and dashed black 
trace (R2 = 0.99) represent the calibration curve obtained by recording the ratio of the 1H 
NMR signals at 31.8 ppm and 33.0 ppm upon mixing known concentrations of complexes 4 
and 5.
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Scheme 1. 
General molecular structure of complexes 1–3, supported by pyrazolates and a 1,3,5- 
triarylbenzene-based ligand (L). The inset shows the coloring scheme for the apical and core 
metal centers.
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Table 1
Oxidation potential and reactivity pathways for complexes 1–3.
# E½ ( Fc/Fc
+)
MIII2MII2/MIII3MII
C(sp2)–F vs. C(sp2)–H Oxygenation
Preferred Pathway Ratioa
1 − 0.08 V C(sp2)–F > 8:1
2 − 0.02 V C(sp2)–H 1:1 – 1:2
3 + 0.26 V C(sp2)–H ND
a
Determined my mass spectrometry and 1H NMR spectroscopy; see Figure 1F, Figure 2, and the supporting information for experimental details.
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